SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is experiencing strong upward momentum as traders react to broad sector tailwinds and optimism surrounding its AI data center growth, with many discussing the potential for further gains while some express caution over the stock's valuation. Discussion remains polarized between bullish traders targeting higher levels based on AI accelerator demand and bears who view the recent price action as unsustainable or manipulated.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as the stock surges following a collaboration update with ASML regarding High NA EUV technology and news that the company reportedly plans to raise CPU prices. Community sentiment is largely bullish, with many traders viewing the stock as a recovery play and a beneficiary of U.S. government support, though some remain skeptical and point to potential volatility.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm shares are facing downward pressure as investors digest mixed sentiment surrounding the company's long-term growth prospects, despite a robust pipeline of partnerships in automotive and AI infrastructure. Traders are debating whether the stock's current valuation represents a buying opportunity or a structural decline due to persistent concerns over handset market dependency and upcoming competition.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is attracting attention following its finalized $100 million quantum research agreement with the U.S. Department of Commerce. While the funding agreement has generated optimism about the company's roadmap and government support, investors are debating the potential for share dilution and questioning the company's long-term profitability in a volatile quantum sector.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as traders focus on the company's upcoming September commercial updates and production milestones, specifically centered around the CIOE and ECOC industry conferences. While speculation regarding potential partnerships and shipment progress remains high, sentiment is divided between investors anticipating an imminent breakout based on these catalysts and skeptics questioning the company's timeline and communication transparency.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following an active Investor Day that featured an unveiled quantum platform, a raised full-year 2026 revenue outlook, and a significant quantum-security agreement with Congruity360. Investors are reacting to these announcements with a mix of optimism regarding commercialization and skepticism over the company's long-term profitability and revenue growth.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as traders debate the company's valuation and debt load against its strong revenue backlog and position in the AI infrastructure sector. While some investors remain bullish on the company's long-term growth and partnerships, others are concerned by consistent insider selling and broader market volatility affecting speculative AI-linked names.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending as traders speculate on potential contracts, particularly with the Tennessee Valley Authority, while community sentiment remains divided between long-term confidence in its nuclear technology for AI data center energy and skepticism regarding the company's lack of revenue and ongoing share dilution.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending following a significant share price decline, which traders attribute to BMO Capital's downgrade to Market Perform and market concerns regarding 'read-through' risk from a failed late-stage clinical trial by Novartis for a competing drug in the same drug class. While some investors view the sell-off as an excessive sympathy move, others note that the market is re-evaluating the valuation of Amgen's pipeline in light of the clinical failure of the rival drug.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis is trending following the announcement that its Phase 3 HARBOR study of del-desiran failed to meet the primary endpoint in treating myotonic dystrophy type 1, marking the company's third trial setback in a short period. Traders and the community are expressing concern over the impact of these clinical failures on the company's pipeline and future M&A strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
